Header Logo

Connection

JULIE GASTIER-FOSTER to Daunorubicin

Back to Details
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Daunorubicin.
JULIE GASTIER-FOSTER
Connection Strength
0.151
Daunorubicin
  1. No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. Pediatr Blood Cancer. 2019 06; 66(6):e27681.
    View in: PubMed
    Score: 0.151
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.